（原标题：韩第62届贸易日：有望达成史上最大出口额） 据韩联社12月4日报道，产业通商部与贸协当日举行了第62届"贸易日"纪念仪式，1000余名贸易有 功人士及政府、相关机构人士出席，今年1月至11月，韩国累计出口额达6402亿美元，创2022年以来近 三年新高。韩国出口有望首次突破7000亿美元大关。出口连续6个月实现正增长，呈现"先抑后扬"的良 好态势。今年，韩国出口由半导体、汽车、船舶、生物等主力制造业凭借强大竞争力领跑。随着韩流在 全球扩散，K-食品、K-美妆等消费品以及军工产品也取得亮眼成绩，为出口增长助力。出口市场结构 也逐步拓展实现多元化。此外，今年第三季度，出口中小企业数量达8.9万家，创历史新高；中小企业 出口额达871亿美元，也创下历史最高纪录，出口基础不断扩大。纪念仪式上，598名个人和1689家企业 因对韩国出口作出贡献而受到表彰。 ...

Core Points - The company is Shandong Sinobioway Biomedicine Co., Ltd., established in accordance with Chinese laws and regulations, with a registered capital of RMB 659,735,586 [2][6] - The company focuses on the biomedicine sector, aiming to address health issues through pharmaceutical research, manufacturing, and related services [4][5] - The company was approved for its initial public offering (IPO) in 2011, issuing 27.08 million shares [3] Company Structure - The company is a permanent corporation, with its legal representative being the board director or general manager [2][8] - The company has a total of 659,735,586 shares, all of which are ordinary shares [7][21] - The company is governed by its articles of association, which are legally binding for the company, shareholders, and management [3][12] Business Operations - The company's business scope includes biotechnology research, production and sales of pharmaceuticals, medical devices, and health management services [5][14] - The company aims to enhance its competitive edge in both domestic and international markets by integrating resources and improving innovation capabilities [4][14] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and participation in company decisions, as well as obligations to comply with laws and the company's articles of association [13][40] - The company has provisions for shareholder meetings, including the requirement for a quorum and voting procedures [20][79] Governance and Compliance - The company is required to maintain transparency and comply with regulations regarding shareholder rights, including the disclosure of significant events [18][19] - The articles of association outline the responsibilities of controlling shareholders and actual controllers to protect the interests of the company and other shareholders [41][42]